Although many efforts have been made to investigate a promising biomarker for the diagnosis of papillary thyroid cancer (PTC), the currently available biomarkers lack the sensitivity to accurately characterize PTC. Here, we established a high-sensitivityt cell-free DNA (cfDNA) detection system using polydopamine-silica (PDA/SiO2) hybrids to enable clinically reliable analysis of PTC. The PDA/SiO2-coated beads improved the detection of DNA by 1.76-fold (p=0.031) compared to the conventional silica-based cfDNA capture system. The PDA-SiO2-coated beads were then applied for the detection of cfDNA from serum samples obtained from 37 PTC patients, and the BRAFV600E mutation status in captured DNA was analyzed using both quantitative polymerase chain reaction (qPCR) and digital droplet PCR (ddPCR). The BRAFV600E mutation status analyzed using both assays demonstrated a strong correlation with the multifocality of PTC, exhibiting area under receiver operating characteristic curve (AUC-ROC) of >0.964 (p<0.001). In contrast, none of the serum antigens or antibodies related to PTC or thyroid functions exhibited clinically significant prediction for detecting PTC patients with multifocal tumors. These findings suggest that cfDNA capture using PDA/ SiO2-coated beads is a promising approach for analyzing the BRAF mutation, which can serve as an excellent diagnostic biomarker for PTC.
Prete A, de Souza PB, Censi S, Muzza M, Nucci N, Sponziello M, Front. Endocrinol., 11, 102, 2020
Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, J. Clin. Endocrinol. Metab., 90(12), 6373, 2005
Xing M, Alzahrani AS, Carson KA, Shong YK, Kim TY, Viola D, Elisei R, Bendlová B, Yip L, Mian C, Vianello F, Tuttle RM, J. Clin. Oncol., 33(1), 42, 2015
Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, Robenshtok E, Jama, 309(14), 1493, 2013
Ge J, Wang J, Wang H, Jiang X, Liao Q, Gong Q, Mo Y, Li X, Li G, Xiong W, Zhao J, Zeng Z, Ge J, J. Cancer, 11(4), 932, 2020
Campbell MJ, Seib CD, Candell L, Gosnell JE, Duh QY, Clark OH, Shen WT, World J. Surg., 39(3), 695, 2015
Finkel A, Liba L, Simon E, Bick T, Prinz E, Sabo E, Izhak OB, Hershkovitz D, J. Clin. Endocrinol. Metab., 101(4), 1407, 2016
Guerra A, Sapio MR, Marotta V, Campanile E, Rossi S, Forno I, Fugazzola L, Budillon A, Moccia T, Fenzi G, Vitale M, J. Clin. Endocrinol. Metab., 97(2), 517, 2012
Pupilli C, Pinzani P, Salvianti F, Fibbi B, Rossi M, Petrone L, Perigli G, De Feo ML, Vezzosi V, Pazzagli M, Orlando C, Forti G, J. Clin. Endocrinol. Metab., 98(8), 3359, 2013
Jensen K, Thakur S, Patel A, Mendonca-Torres MC, Costello J, Gomes-Lima CJ, Walter M, Wartofsky L, Burman KD, Bikas A, Ylli D, J. Clin. Med., 9(8), 2481, 2020
Kim BH, Kim IJ, Lee BJ, Lee JC, Kim IS, Kim SJ, Kim WJ, Jeon YK, Kim SS, Kim YK, Yonsei Med. J., 56(3), 634, 2015
Lee T, Rawding PA, Bu J, Hyun S, Rou W, Jeon H, Kim S, Lee B, Kubiatowicz LJ, Kim D, Hong S, Eun H, Cancers, 14(9), 2061, 2022
Bu J, Lee TH, Jeong WJ, Poellmann MJ, Mudd K, Eun HS, Liu EW, Hong S, Hyun SH, PloS One, 15(12), e0242145, 2020
Kimbrell HA, Sholl AB, Ratnayaka S, Japa S, Lacey M, Carpio G, Bhatia P, Kandil E, BioMed. Res. Int., 2015, 486391, 2015
Li C, Lee KC, Schneider EB, Zeiger MA, J. Clin. Endocrinol. Metab., 97(12), 4559, 2012
Jeong D, Jeong Y, Park JH, Han SW, Kim SY, Kim YJ, Kim SJ, Hwangbo Y, Park S, Cho HD, Oh MH, Yang SH, Kim CJ, Ann. Surg. Oncol., 20(3), 759, 2013
Bu J, Lee TH, Poellmann MJ, Rawding PA, Jeong WJ, Hong RS, Hyun SH, Eun HS, Hong S, Clin. Transl. Med., 11(8), e499, 2021
Prpić M, Franceschi M, Romić M, Jukić T, Kusić Z, Acta Clinica Croat., 57(3), 518, 2018
Indrasena BSH, World J. Biol. Chem., 8(1), 81, 2017
Zhao CK, Zheng JY, Sun LP, Xu RY, Wei Q, Xu HX, Cancer Med., 8(12), 5577, 2019